Women-only HIV study improves understanding of effective, safe antiretroviral … – Vaccine News Daily


Vaccine News Daily

Women-only HIV study improves understanding of effective, safe antiretroviral
Vaccine News Daily
The Women's Antiretroviral Efficacy and Safety Study (WAVES) was the first double-blind, randomized, antiretroviral (ARV) trial that involved only women. The purpose was to demonstrate the women using Stribild would have a statistically higher chance

and more »

Leave a Reply

Your email address will not be published.

Back to Top